BR9916726A - HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes - Google Patents

HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes

Info

Publication number
BR9916726A
BR9916726A BR9916726-3A BR9916726A BR9916726A BR 9916726 A BR9916726 A BR 9916726A BR 9916726 A BR9916726 A BR 9916726A BR 9916726 A BR9916726 A BR 9916726A
Authority
BR
Brazil
Prior art keywords
mobilization
growth hormone
human growth
stimulate
stem cells
Prior art date
Application number
BR9916726-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Alessandro Massimo Gianni
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR9916726A publication Critical patent/BR9916726A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9916726-3A 1998-12-30 1999-12-30 HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes BR9916726A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
BR9916726A true BR9916726A (pt) 2001-09-11

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916726-3A BR9916726A (pt) 1998-12-30 1999-12-30 HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes

Country Status (15)

Country Link
US (1) US20060029581A1 (cg-RX-API-DMAC7.html)
EP (3) EP1016413A1 (cg-RX-API-DMAC7.html)
JP (1) JP4808316B2 (cg-RX-API-DMAC7.html)
AT (1) ATE342064T1 (cg-RX-API-DMAC7.html)
AU (2) AU772222B2 (cg-RX-API-DMAC7.html)
BR (1) BR9916726A (cg-RX-API-DMAC7.html)
CA (1) CA2354194A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107603T1 (cg-RX-API-DMAC7.html)
DE (1) DE69933581T2 (cg-RX-API-DMAC7.html)
DK (1) DK1140149T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275359T3 (cg-RX-API-DMAC7.html)
IL (2) IL143994A0 (cg-RX-API-DMAC7.html)
PT (1) PT1140149E (cg-RX-API-DMAC7.html)
SI (1) SI1140149T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000040260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム リサーチ ディベロップメント カンパニー 胚性細胞の定方向分化
CN102302493B (zh) 2001-07-31 2015-08-12 健赞股份有限公司 活化祖细胞/干细胞的方法
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
BRPI0519170A8 (pt) * 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス,インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
JPH08511263A (ja) * 1993-06-15 1996-11-26 ブリテッシュ バイオテック ファーマシューティカルズ リミテッド 造血細胞の放出と可動化
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
CA2227241C (en) * 1995-07-21 2004-12-21 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
EP1779865A1 (en) 2007-05-02
CY1107603T1 (el) 2013-03-13
IL143994A (en) 2009-06-15
DE69933581D1 (de) 2006-11-23
AU2103900A (en) 2000-07-24
EP1140149A1 (en) 2001-10-10
WO2000040260A1 (en) 2000-07-13
SI1140149T1 (sl) 2007-02-28
DK1140149T3 (da) 2007-02-19
JP4808316B2 (ja) 2011-11-02
AU772222B2 (en) 2004-04-22
US20060029581A1 (en) 2006-02-09
DE69933581T2 (de) 2007-06-21
AU2004203355B2 (en) 2007-05-17
CA2354194A1 (en) 2000-07-13
AU2004203355A1 (en) 2004-08-19
JP2002534393A (ja) 2002-10-15
PT1140149E (pt) 2007-01-31
IL143994A0 (en) 2002-04-21
ES2275359T3 (es) 2007-06-01
EP1016413A1 (en) 2000-07-05
ATE342064T1 (de) 2006-11-15
EP1140149B1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
DK1226233T3 (da) Multipotente voksne stamceller og fremgangsmåder til isolering heraf
AR025683A1 (es) Composiciones de d-endotoxina de bacillus thuringiensis activas contra lepidopteros y metodos de uso
WO2003029418A3 (en) Proliferation and differentiation of stem cells using extracellular matrix and other molecules
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
AR053383A2 (es) Celulas vegetales transformadas, plantas que las contienen y uso de una construccion de adn en un metodo
ES2061720T3 (es) Transformacion de tejido vegetal.
BRPI0413002A (pt) genes de ciclo de célula de planta e métodos de uso
WO2003004605A3 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
WO2001021766A3 (en) Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
EP1424389A4 (en) METHOD FOR PRODUCING HEMATOPOETIC STEM CELLS
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
WO2005047524A3 (en) Compositions and methods for inducing cell dedifferentiation
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
WO2003059276A3 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
GB2394826A (en) Educational game
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
EP1660682A4 (en) ANTISENSE MODULATION OF P38 MITOGEN-ACTIVATED PROTEIN KINASE EXPRESSION
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
ATE514771T1 (de) Haartransplantation
ES2196172T3 (es) Transplante neuronal utilizando celulas neuroepiteliales pluripotentes.
DE60044655D1 (de) Angereicherte Zellpopulationen des zentralen Nervensystems
WO2002083888A3 (en) The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
AR036402A1 (es) Efecto de la hormona de crecimiento y de igf-1 sobre celulas madre neuronales.
DE60324948D1 (de) Herstellungsverfahren für iturin a und dessen homologe

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13, 24, 25 E 10 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 38/27; C12N 5/06; C12N 5/08; A61K 35/14; A61K 35/28.

Ipc: A61K 38/27 (2006.01), A61K 35/00 (2006.01)

Ipc: A61K 38/27 (2006.01), A61K 35/00 (2006.01)